Results 191 to 200 of about 22,577 (254)

Al-Bi₂Se₃-Al Nanoribbon Josephson Junctions with Fabry-Pérot Interference: Implications for Phase-Coherent Topological Insulator-Based Superconducting Devices. [PDF]

ACS Appl Nano Mater
Niherysh K, Trnjanin N, Surendran AP, Kunakova G, Palermo X, Montemurro D, Andzane J, Erts D, Golubev DS, Lara-Avila S, Lombardi F, Bauch T.   +11 more
europepmc   +1 more source

From diagnosis to disease-specific treatment: first experience with enzyme replacement therapy for Fabry disease in North Macedonia-a case series. [PDF]

Front Med (Lausanne)
Karanfilovski V, Nikolov IG, Dzekova Vidimliski P, Balkanov SK, Severova G, Stojanoska A, Gjorgjievski N.   +6 more
europepmc   +1 more source

Regarding: "Development and validation of a self-management efficacy questionnaire for patients with Fabry disease in China". [PDF]

Ann Med
Zhao D, Zhou W.
europepmc   +1 more source

Performance-Enhanced Fiber-Optic Hydrogen Sensing Method Based on a Pd-Cu Alloy Microcantilever and a Reflective Enhancement Structure. [PDF]

Sensors (Basel)
Wang Q, Wu Q, Jia Y, Jiang J, Jin Z, Du J.   +5 more
europepmc   +1 more source

Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment. [PDF]

Orphanet J Rare Dis
Graziani F, Biagini E, Argirò A, Citro R, Iaccarino G, Lanzillo C, Monte I, Pieruzzi F, Zuchi C, Pieroni M.   +9 more
europepmc   +1 more source

Genome sequencing reveals the prevalence of Fabry disease-causing variants in Japan: Evidence from the Tohoku Medical Megabank. [PDF]

Genet Med Open
Susukita K, Nochioka K, Takase M, Yamamoto S, Kumada K, Suzuki H, Ohneda K, Noguchi K, Izumi Y, Ogishima S, Nakaya N, Eto Y, Hozawa A, Yasuda S.   +13 more
europepmc   +1 more source

Generation of the functionally enhanced proximal tubular cells from human iPSC-derived kidney organoids. [PDF]

Exp Mol Med
Kim S, Nam SA, Kim JW, Yi J, Woo JJ, Lee M, Lee J, Kim TH, Kim H, Kim HW, Park J, Kim YK.   +11 more
europepmc   +1 more source

Novel GLA variant (c.752A>C; p.Glu251Ala) identified in a patient with Fabry cardiomyopathy and familial segregation. [PDF]

Front Mol Biosci
Zhang T, Huang S, Huang F.
europepmc   +1 more source

Prevalence and determinants of asymmetric septal hypertrophy (ASH) in diseases of left ventricular hypertrophy (LVH). [PDF]

Eur Heart J Cardiovasc Imaging
Shiwani H, Augusto J, Topriceanu CC, Ioannou A, Rosmini S, Maestrini V, Hughes R, Knott K, Bhuva A, Dowsing B, Artico J, Pierce I, Treibel T, Howard J, Manisty C, Kellman P, Kozor R, Steeds R, Captur G, Mohiddin S, Lopes L, Fontana M, Moon J, Davies R.   +23 more
europepmc   +1 more source